Droxinavir

Drug Profile

Droxinavir

Alternative Names: SC 55389A

Latest Information Update: 22 Dec 1995

Price : $50

At a glance

  • Originator Pharmacia Corporation
  • Class Antivirals
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 22 Dec 1995 SC 55389A is now called droxinavir
  • 06 Mar 1995 Discontinued-Preclinical for HIV infections treatment in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top